EPISODE · Jul 17, 2025 · 8 MIN
In conversation with... Amit Bar-Or
from Listen to The Lancet Neurology · host The Lancet
In this episode, host Laura Hart chats with Professor Amit Bar-Or (University of Pennsylvania) about the potential of the BTK inhibitor fenebrutinib in treating relapsing multiple sclerosis, highlighting future challenges in MS research.
NOW PLAYING
In conversation with... Amit Bar-Or
0:00
8:10
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Neurology?
This episode is 8 minutes long.
When was this Listen to The Lancet Neurology episode published?
This episode was published on July 17, 2025.
What is this episode about?
In this episode, host Laura Hart chats with Professor Amit Bar-Or (University of Pennsylvania) about the potential of the BTK inhibitor fenebrutinib in treating relapsing multiple sclerosis, highlighting future challenges in MS research.
Can I download this Listen to The Lancet Neurology episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!